OSF Breakthrough Treatment Center

At the OSF Breakthrough Treatment Center, we provide cutting-edge cancer therapies through advanced clinical trials.

Joining a clinical trial gives you access to the latest treatments, especially if previous therapies have not succeeded. Our world-class care teams, led by top physicians, use the latest technologies and global research.

Our center collaborates with Origin for swift access to promising global cancer therapies. Serving both adults and children, we seamlessly integrate with our health system, ensuring a smooth journey for patients and families. In our first year, we expanded participation in groundbreaking trials, advancing cancer detection and curability technologies.

In addition to pioneering research in many types of cancer, OSF was selected to become a member of the Gynecologic Oncology Group (GOG), which offers patients access to advanced and innovative treatments. 

How to Access a Clinical Trial

We’re Here for You

If you are interested in participating, please complete this request form, or call 1-844-OSF-4-HOPE (1-844-673-4467).

Our team is available Monday – Friday from 8 a.m. to 4:30 p.m.


Pioneering pancreatic cancer detection

In its first year, the OSF Breakthrough Treatment Center became one of only 10 sites in the world to pioneer a new National Institutes of Health (NIH) study for pancreatic cancer detection. This blood test uses special biomarkers to create a unique RNA fingerprint, helping us catch diseases or their return early on.

Detecting lung cancer early

The OSF Breakthrough Treatment Center is enrolled in a groundbreaking lung cancer early detection trial. It’s the second site in the world chosen to provide a method for easy mass-produced lung cancer screenings which can detect lung cancer earlier than ever before.

Looking ahead

The center is exploring new ways to treat brain cancer using artificial intelligence, find ovarian cancer early in a groundbreaking way, study advanced molecular tumor profiling, develop treatments for glioblastoma and ovarian cancer and create new technologies to detect multiple diseases early on.